Advanced search
Publication Cover
Journal of Drug Targeting Volume 18, 2010 - Issue 7
Submit an article Journal homepage
546
Views
81
CrossRef citations to date
0
Altmetric
Research Article

Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery

Himanshu GuptaInstitute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organization, Delhi, India
,
T. VelpandianOcular Pharmacology Department, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India
&
Sanyog JainNational Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab, IndiaCorrespondence[email protected], [email protected]
Pages 499-505 | Received 16 Aug 2009, Accepted 24 Nov 2009, Published online: 08 Jan 2010

References

  • Balasubramaniam J, Kant S, Pandit JK. (2003). In vitro and in vivo evaluation of the Gelrite gellan gum-based ocular delivery system for indomethacin. Acta Pharm, 53: 251–261.
  • Balasubramaniam J, Pandit JK. (2003). Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Drug Deliv, 10: 185–191.
  • Carlfors J, Edsman K, Petersson R, Jörnving K. (1998). Rheological evaluation of Gelrite in situ gels for ophthalmic use. Eur J Pharm Sci, 6: 113–119.
  • Chiou GCY, Watanabe K. (1986). Drug delivery to the eyes. In: Ihler GM, ed. Methods of Drug Delivery: International Encyclopedia of Pharmacology and Therapeutics (pp. 203–210). UK: Pergamon Press.
  • Desai SD, Blanchard J. (1994). Ocular drug formulation and delivery. In: Swarbick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology (pp. 43–75). vol. 11. New York: Marcel Dekker.
  • Felt O, Buri P, Gurny R. (1998). Chitosan: a unique polysaccharide for drug delivery. Drug Dev Ind Pharm, 24: 979–993.
  • Felt O, Baeyens V, Zignani M, Bury P, Gurny R. (1999a). Mucosal drug delivery: ocular. In: Mathiowith E, ed. Encyclopedia of Controlled Drug Delivery (pp. 605–626). vol. 1. New York: John Wiley & Sons.
  • Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. (1999b). Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm, 180: 185–193.
  • Gupta H, Aqil M, Khar RK, Ali A, Bhatnagar A, Mittal G, Jain S. (2009). Development and characterization of 99mTc-timolol maleate for evaluating efficacy of in situ ocular drug delivery system. AAPS PharmSciTech, 10: 540–546.
  • Gupta H, Jain S, Mathur R, Mishra P, Mishra AK, Velpandian T. (2007). Sustained ocular drug delivery from a temperature and pH triggered novel in situ gel system. Drug Deliv, 14: 507–515.
  • Gurny R, Ibrahim H, Buri P. (1993). The development and use of in-situ formed gels triggered by pH. In: Edman Y, ed. Biopharmaceutics of Ocular Drug Delivery (pp. 81–90). FL, USA: CRC Press.
  • Higashiyama M, Inada K, Ohtori A, Tojo K. (2004). Improvement of the ocular bioavailability of timolol by sorbic acid. Int J Pharm, 272: 91–98.
  • Maurice DM. (1987). Kinetics of topically applied drugs. In: Saettone MS, Bucci P, eds. Ophthalmic Drug Delivery: Biopharmaceutical, Technological and Clinical Aspects (pp. 19–26). vol. 11. Padova: Fidia Research Series, Liviana Press.
  • Middleton DL, Leung SS, Robinson JR. (1990). Ocular bioadhesive delivery systems. In: Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery Systems (pp. 179–202). Boca Raton: CRC Press.
  • Ranade VV, Hollinger MA. (1996). Drug Delivery Systems. Boca Raton, FL, USA: CRC Press.
  • Rozier A, Mazuel C, Grove J, Plazonnet B. (1989). Gelrite®: a novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles: effect on bioavailability of timolol. Int J Pharm, 57: 163–168.
  • Schoenwald RD. (1990). Ocular drug delivery. Pharmacokinetic considerations. Clin Pharmacokinet, 18: 255–269.
  • Spielmann H. (1997). Ocular irritation. In: Castle JV, Gomez MJ, eds. In Vitro Methods in Pharmaceutical Research (pp. 265–287). San Diego, CA: Academic Press.
  • Srividya B, Cardoza RM, Amin PD. (2001). Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system. J Control Release, 73: 205–211.
  • Sultana Y, Aqil M, Ali A. (2006). Ion-activated, Gelrite-based in situ ophthalmic gels of pefloxacin mesylate: comparison with conventional eye drops. Drug Deliv, 13: 215–219.
  • Velpandian T, Bankoti R, Humayun S, Ravi AK, Kumari SS, Biswas NR. (2006). Comparative evaluation of possible ocular photochemical toxicity of fluoroquinolones meant for ocular use in experimental models. Indian J Exp Biol, 44: 387–391.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.